AFT Pharmaceuticals Limited logo

Arrangements for the Adjourned 2020 Annual Meeting

AGM23 August 2020AFTHealthcare

103372.1 - 1166057-1
Market release 21 August 2020

Arrangements for the Adjourned 2020 Annual Meeting

AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) has provided a copy of its

Notice of Adjourned Annual Meeting of Shareholders 2020 advising that the Annual

Meeting of shareholders of AFT scheduled for 12 August 2020 will be convened and

held on a fully virtual basis on Tuesday, 8 September 2020 at 10.30am (New Zealand

time) to transact the business set out in the Notice of Annual Meeting of

Shareholders 2020 dated 15 July 2020. A copy of the Notice of Adjourned Annual

Meeting of Shareholders 2020 will be sent to shareholders.

ENDS

- Released for and on behalf of AFT Pharmaceuticals Limited by Chief Financial Officer Malcolm Tubby

For more information

Investors Media

Malcolm Tubby Richard Inder

CFO The Project

AFT Pharmaceuticals +64 21 645 643

Tel: +64 9 488 0232

About AFT Pharmaceuticals

A

FT is a growing multinational pharmaceutical company that develops, markets and distributes a broad

portfolio of pharmaceutical products across a wide range of therapeutic categories which are

distributed across all major pharmaceutical distribution channels: over the counter (OTC), prescription

and hospital. Our product portfolio comprises both proprietary and in-licensed products, and includes

patented, branded and generic drugs. Our business model is to develop and in-license products for sale

by our own dedicated sales teams in our home markets of Australia and New Zealand and in certain

Southeast Asian markets, and to out-license our products to local licensees and distributors to the rest of

the world.

---

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN 609 017 969

Notice of Adjourned Annual Meeting of Shareholders 2020

Notice is hereby given that the adjourned Annual Meeting of shareholders of AFT Pharmaceuticals Limited

(AFT or the Company) will be convened and held on a fully virtual basis on Tuesday, 8 September 2020

commencing at 10.30am (New Zealand time) to transact the business set out in the Notice of Annual

Meeting of Shareholders 2020 dated 15 July 2020 (Original AGM Notice).

The Original AGM Notice was sent to shareholders on 15 July 2020 and is available on the Company’s

website (https://investors.aftpharm.com/Investors/?page=Meetings) and the NZX website

(https://www.nzx.com/announcements/356233).

Shareholders

can participate in the Annual Meeting virtually through the web platform web.lumiagm.com,

or by downloading the Lumi AGM app, and entering the meeting ID 323-946-452. To participate,

shareholders will need their CSN/Securityholder number which can be found on their proxy f orm which

accompanied the Original AGM Notice. Shareholders will be able to view presentations, ask questions

and cast their vote from their own computers, mobiles or similar devices. Participants who are not

shareholders will be able to log in as guests.

Further step by step details are set out in the attached Virtual Meeting Guide. If shareholders have any

questions, or need assistance with the online process, please contact Computershare on +64 9 488 8777

between 8.30am – 5.00pm (New Zealand time), Monday to Friday.

Proxy forms submitted before 10.30am (New Zealand time) Monday, 10 August 2020 (Proxy Deadline)

remain valid for the adjourned Annual Meeting. The Company is not able to accept proxy forms

submitted after the Proxy Deadline. If you submitted a proxy form before the Proxy Deadline and now

wish to withdraw it, please contact the Company at investor.relations@aftpharm.com or Computershare

on +64 9 488 8777 before 10.30am (New Zealand time) on Tuesday, 8 September 2020.

AFT would like to thank all shareholders for their patience and co-operation in enabling us to hold our

adjourned Annual Meeting via virtual means amidst the current COVID-19 pandemic.

By Order of the AFT Pharmaceuticals Limited Board

David Flacks

Chairman

21 August 2020

---

VOTING AT A GLANCE
STEP 1

Open Lumi AGM and enter the

Meeting ID shown in top right

corner

STEP 2

Enter your username and

password (CSN/Holder Number

and postcode)

STEP 3

When the poll is opened,

click and select your

desired voting direction

Virtual meetings are accessible on both desktop and mobile devices. In order to participate remotely you will need to either:

>Visit web.lumiagm.com on your desktop or mobile device. Ensure that your browser is compatible—Lumi AGM supports the latest

versions of Chrome, Safari, Internet Explorer, Edge and Firefox; or

>Download Lumi AGM from the App Store or Google Play Stores for free—search for Lumi AGM.

>If you have any questions, or need assistance with the online process, please contact Computershare on +64 9 488 8777 between

8.30am—5.00pm Monday to Friday (New Zealand time).

Shareholders are encouraged to download the app prior to the Annual Meeting if you will be using a mobile device.

VIRTUAL MEETING GUIDE

LOGGING IN

NEW ZEALAND RESIDENTS

Username (CSN or Holder number) and

password (postcode).

APPOINTED PROXIES

A username and password will be

provided prior to the meeting.

If you have not received your username

and password, please contact

Computershare on +64 9 488 8777

between 8.30am—5.00pm Monday to

Friday (New Zealand time).

MEETING ID

323-946-452

To log in, you must have the following information (which can be found on your Shareholder’s Voting and Proxy Form) or you can login as

a guest if you are not a shareholder in AFT Pharmaceuticals Limited; however, you will not be able to ask any questions or vote.

Remote entry to the Annual Meeting will open at 10.00AM NZT

on Tuesday 8 September 2020, with the meeting commencing

at 10.30AM NZT.

OVERSEAS RESIDENTS

Username (CSN or Holder Number);

and Password (three-character ISO3

country code) e.g. AUS is the ISO3 code

for Australia.

You can find a full list at

www.computershare.com/iso3

USING LUMI AGM
ACCESSING THE VIRTUAL MEETING

Once you have downloaded Lumi AGM

or entered web.lumiagm.com into your

internet browser, you’ll be prompted

to enter the Meeting ID and accept the

terms and conditions.

You will then be required to enter your:

>username (CSN or Holder number);

>password (postcode, or country code

for overseas residents)

NAVIGATING LUMI AGM

When successfully authenticated, the

info screen will display.

You can view meeting information, ask

questions and watch the webcast.

If you would like to watch the webcast,

press the broadcast icon at the

bottom of the screen.

NAVIGATING LUMI AGM - DESKTOP

When successfully authenticated, the

info screen will display.

You can view meeting information, ask

questions and watch the webcast.

If you would like to watch the webcast,

press the ► button to start the

webcast.

WATCHING THE WEBCAST

To watch the webcast, click the black

broadcast bar on screen and push

the ► button to start the webcast.

The video and/or slides will appear

shortly after (dependent on the speed

of your internet connection).

ASKING QUESTIONS

Any shareholder or appointed proxy/

representative attending the meeting

is eligible to ask questions. If you would

like to ask a question, select then

type and submit your question. It will be

sent to the board for an answer.

Please note that not all questions may

be able to be answered during the

meeting. In this case, questions will be

followed up by email after the meeting.

VOTING IN LUMI AGM

Once the poll has been opened, will

appear on the navigation bar at the

bottom of the screen—from here, the

resolution and voting choices will be

displayed.

To vote, simply select your voting

direction from the options shown on

screen. To change your vote, simply

select another direction—you can cancel

your vote by clicking ‘Cancel’.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.